The Peptide Craze Ground Truths BPC 157: Miracle Healing Peptide or Hidden Danger? When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York